Literature DB >> 21521630

Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents?

Diana I Simeonova1, Ashraf Attalla, Hanan Trotman, Michelle Esterberg, Elaine F Walker.   

Abstract

Recent research on risk for psychosis has focused on youth who manifest subclinical signs that are often associated with the prodrome to psychosis. Standardized measures of prodromal symptoms have been shown to significantly enhance prediction of risk for conversion to an Axis I psychotic disorder. In the present study, a widely used parent-report measure of behavioral problems, the Child Behavior Checklist (CBCL) was administered to examine the clinical and diagnostic utility of the measure as an adjunctive screening instrument in the identification of at-risk youth. The CBCL, the Structured Interview for Prodromal Syndromes (SIPS), and other diagnostic measures were administered at baseline and at one year follow-up assessments to adolescents (n=41) at clinical high-risk for the development of a psychotic disorder. Analyses were conducted to compare the 14 at-risk adolescents who subsequently converted to psychosis to the 27 who did not. Conversion to psychosis was defined as conversion to an Axis I psychotic disorder or affective disorder with psychotic features. Consistent with expectations, at one year follow-up, compared to the Non-Converted participants, the Converted participants manifested significantly higher scores on the prodromal symptom scales of the SIPS. There were, however, no differences in CBCL social and behavioral ratings as a function of conversion status. It is concluded that the CBCL does not show promise as an alternative or adjunctive predictor of conversion to psychosis in at-risk adolescents.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21521630      PMCID: PMC3139757          DOI: 10.1016/j.schres.2011.03.034

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  32 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

2.  Parent-adolescent agreement on emotional and behavioral problems.

Authors:  A Sourander; L Helstelä; H Helenius
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1999-12       Impact factor: 4.328

3.  Social adjustment of adolescents at risk for schizophrenia: the Jerusalem Infant Development Study.

Authors:  S L Hans; J G Auerbach; J R Asarnow; B Styr; J Marcus
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-11       Impact factor: 8.829

4.  The effects of parental psychopathology and maltreatment on child behavior: a test of the diathesis-stress model.

Authors:  E Walker; G Downey; A Bergman
Journal:  Child Dev       Date:  1989-02

5.  Patterns of childhood social development in adult schizophrenics.

Authors:  N F Watt
Journal:  Arch Gen Psychiatry       Date:  1978-02

6.  Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study.

Authors:  Scott W Woods; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2009-04-21       Impact factor: 9.306

7.  Information processing and attentional functioning in the developmental course of schizophrenic disorders.

Authors:  K H Nuechterlein; M E Dawson
Journal:  Schizophr Bull       Date:  1984       Impact factor: 9.306

8.  Classifying psychiatric disorders after traumatic brain injury and orthopaedic injury in children: adequacy of K-SADS versus CBCL.

Authors:  Renske Wassenberg; Jeffrey E Max; Sharon L Koele; Kathrina Firme
Journal:  Brain Inj       Date:  2004-04       Impact factor: 2.311

9.  Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Shona M Francey; Colleen A McFarlane; Mats Hallgren; Patrick D McGorry
Journal:  Schizophr Res       Date:  2003-03-01       Impact factor: 4.939

10.  Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.

Authors:  Alison R Yung; Lisa J Phillips; Hok Pan Yuen; Patrick D McGorry
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  5 in total

1.  Does the Fast Track Intervention Prevent Later Psychosis Symptoms?

Authors:  Natalie Goulter; Robert J McMahon; Kenneth A Dodge
Journal:  Prev Sci       Date:  2019-11

Review 2.  Clinical high risk for psychosis in children and adolescents: a systematic review.

Authors:  Jordina Tor; Montserrat Dolz; Anna Sintes; Daniel Muñoz; Marta Pardo; Elena de la Serna; Olga Puig; Gisela Sugranyes; Inmaculada Baeza
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-09-15       Impact factor: 4.785

3.  Longitudinal investigation of the relationship between family history of psychosis and affective disorders and Child Behavior Checklist ratings in clinical high-risk adolescents.

Authors:  Diana I Simeonova; Frances J Lee; Elaine F Walker
Journal:  Schizophr Res       Date:  2015-05-14       Impact factor: 4.939

4.  Psychosis risk screening in clinical high-risk adolescents: a longitudinal investigation using the Child Behavior Checklist.

Authors:  Diana I Simeonova; Theresa Nguyen; Elaine F Walker
Journal:  Schizophr Res       Date:  2014-08-27       Impact factor: 4.939

5.  Combined pattern of childhood psycho-behavioral characteristics in patients with schizophrenia: a retrospective study in Japan.

Authors:  Yukiko Hamasaki; Takao Nakayama; Takatoshi Hikida; Toshiya Murai
Journal:  BMC Psychiatry       Date:  2021-01-26       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.